One-third of malaria cases cut by vit A and zinc

25 February 2008

A study in the Nutrition Journal has found that dietary supplements for children can reduce the incidence of malaria by one third. A combination of vitamin A and zinc was found to improve the ability of children aged six months to six years in Burkina Faso to resist the disease.

The placebo-controlled research was carried out by the Burkina Faso Health Sciences Research Institute (IRSS). Speaking to the UK public broadcaster, the BBC, Ron Berens, a tropical diseases expert at the London School of Hygiene and Tropical Medicine, acknowledged that zinc supplements have positive effects on a number of diseases, but that the benefits for malaria might be restricted to populations suffering from specific malnutrition problems. Dr Berens said: "neither of these micronutrients is totally safe. They should be used like pharmaceuticals and not seen as cure-alls."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight